Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Pietro Ghedini"'
Publikováno v:
Pharmaceuticals, Vol 15, Iss 3, p 343 (2022)
[68Ga]Ga-PSMA-11 PET/CT plays a pivotal role in the diagnosis and staging of prostate cancer because of its higher sensitivity and detection rate compared with traditional choline PET/CT. A highly reproducible radiochemical yield of the radiopharmace
Externí odkaz:
https://doaj.org/article/d4c6d5d1203c4315beffa2a7011f8f36
Publikováno v:
Journal of Cancer and Allied Specialties, Vol 1, Iss 2 (2015)
Externí odkaz:
https://doaj.org/article/fa257ebaf11c45ae9a7e22072590f2fa
Autor:
Valeria Dionisi, Stefano Fanti, Fabio Monari, Pietro Ghedini, Alessio G. Morganti, Elisa Lodi Rizzini
Publikováno v:
Scientific Reports, Vol 10, Iss 1, Pp 1-11 (2020)
Scientific Reports
Scientific Reports
Bone is the most common site of metastasis in metastatic castration-resistant prostate cancer (mCRPC), which is associated with pain and skeletal events. Radium-223 dichloride (Xofigo) is an alpha-emitting radioactive isotope that can specifically ta
Autor:
Saeed Elojeimy, Henri J L M Timmers, Neeta Pandit-Taskar, Rodney J. Hicks, Anca M. Avram, Stefano Fanti, Aaron T. Scott, David Taïeb, Elif Hindié, Benjamin Guillet, Domenico Rubello, Karel Pacak, Pietro Ghedini, Irene Virgolini, Sona Balogova
Publikováno v:
European Journal of Nuclear Medicine and Molecular Imaging
European Journal of Nuclear Medicine and Molecular Imaging, Springer Verlag (Germany), 2019, 46 (10), pp.2112-2137. ⟨10.1007/s00259-019-04398-1⟩
European Journal of Nuclear Medicine and Molecular Imaging, 46, 10, pp. 2112-2137
European Journal of Nuclear Medicine and Molecular Imaging, 46, 2112-2137
European Journal of Nuclear Medicine and Molecular Imaging, 2019, 46 (10), pp.2112-2137. ⟨10.1007/s00259-019-04398-1⟩
Eur J Nucl Med Mol Imaging
European Journal of Nuclear Medicine and Molecular Imaging, Springer Verlag (Germany), 2019, 46 (10), pp.2112-2137. ⟨10.1007/s00259-019-04398-1⟩
European Journal of Nuclear Medicine and Molecular Imaging, 46, 10, pp. 2112-2137
European Journal of Nuclear Medicine and Molecular Imaging, 46, 2112-2137
European Journal of Nuclear Medicine and Molecular Imaging, 2019, 46 (10), pp.2112-2137. ⟨10.1007/s00259-019-04398-1⟩
Eur J Nucl Med Mol Imaging
Purpose: Diverse radionuclide imaging techniques are available for the diagnosis, staging, and follow-up of phaeochromocytoma and paraganglioma (PPGL). Beyond their ability to detect and localise the disease, these imaging approaches variably charact
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ee59708ca1fecba1b666d0e06cbd1a47
https://hal-amu.archives-ouvertes.fr/hal-02899034
https://hal-amu.archives-ouvertes.fr/hal-02899034
Autor:
Cristina Nanni, Annibale Versari, Stephane Chauvie, Elisa Bertone, Andrea Bianchi, Marco Rensi, Marilena Bellò, Andrea Gallamini, Francesca Patriarca, Francesca Gay, Barbara Gamberi, Pietro Ghedini, Michele Cavo, Stefano Fanti, Elena Zamagni
Publikováno v:
European Journal of Nuclear Medicine and Molecular Imaging. 45:712-719
FDG PET/CT (18F-fluoro-deoxy-glucose positron emission tomography/computed tomography) is a useful tool to image multiple myeloma (MM). However, simple and reproducible reporting criteria are still lacking and there is the need for harmonization. Rec
Autor:
Lidija Antunovic, Cristina Mosconi, Valentina Ambrosini, Alessandra Musto, Elisabetta Nobili, Lucia Zanoni, Rita Golfieri, Irene Bossert, Tiziano Graziani, Francesco Ceci, Andrea Ardizzoni, S. Zoboli, Stefano Fanti, Paolo Castellucci, Francesco Massari, Pietro Ghedini, Margarita Kirienko, Cristina Nanni, Barbara Melotti, Arturo Chiti
Publikováno v:
European Journal of Nuclear Medicine and Molecular Imaging. 45:751-758
Aim: During our daily clinical practice using 11C-Choline PET/CT for restaging patients affected by relapsing prostate cancer (rPCa) we noticed an unusual but significant occurrence of hypodense hepatic lesions with a different tracer uptake. Thus, w
Autor:
Stefano Fanti, Valeria Dionisi, Pietro Ghedini, Chiara Bellarosa, Raffaele Cardano, Fabio Monari, Elisa Lodi Rizzini, Alessio G. Morganti
Bisphosphonates, a group of inorganic pyrophosphate analogues that prevent the loss of bone density, are commonly used in patients with bone metastases; the calcium-mimetic a-emitter radium-223 dichloride (Ra223) is a bone-targeting therapy used in p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c71483be0e3d63bfb1338d6fbaec3c7d
http://hdl.handle.net/11585/701560
http://hdl.handle.net/11585/701560
The aim of the review is to highlight articles published in 2017 in the Annals of Nuclear Medicine, an official peer-reviewed journal of the Japanese Society of Nuclear Medicine. Among all published manuscripts during the past year, we conducted a su
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2bca7d6305d5a489f23729f7ee88a33a
http://hdl.handle.net/11585/746582
http://hdl.handle.net/11585/746582
Publikováno v:
European journal of nuclear medicine and molecular imaging. 46(1)
The author names in the original version of this article were inversed. Correct author names were reflected here.
Autor:
Eugenio Borsatti, Duccio Volterrani, A. Farnesi, Stefano Fanti, Elisa Lodi Rizzini, Giuseppe Boni, C. Cianci, Elda Lamaj, Carlo Gobitti, Sara Mazzarri, Luca Galli, Lucia Fratino, Roberto Bortolus, Francesco Massari, Fabio Monari, Pietro Ghedini, Valeria Dionisi
Background: Radium-223 (223Ra) chloride, an alpha emitter, has been shown to improve overall survival (OS) and pain control, and to delay skeletal-related events, in patients with castration-resistant prostate cancer (CRPC) and bone metastases. Our r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::389e8c6b673708f3375dc5abd8cc8b06
http://hdl.handle.net/11585/661191
http://hdl.handle.net/11585/661191